We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 427 results
  1. Basiliximab Does Not Impair Airway Mucociliary Clearance of Rats

    Previous studies have shown that immunosuppressive drugs impair the airway mucociliary clearance of rats. However, considering the high specificity...

    Aristides Tadeu Correia, Francine Maria de Almeida, ... Rogerio Pazetti in Inflammation
    Article 17 June 2022
  2. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis

    Primary Sclerosing Cholangitis (PSC) is a progressive cholestatic liver disease with no licensed therapies. Previous Genome Wide Association Studies...

    Jessica Leighton, David E. J. Jones, ... Heather J. Cordell in BMC Medical Genomics
    Article Open access 11 June 2024
  3. Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options

    Inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), necrotizing myopathy (NM), antisynthetase...

    Rachel Zeng, Stefanie Glaubitz, Jens Schmidt in Neurotherapeutics
    Article Open access 08 April 2022
  4. Investigation of interleukin-2-mediated changes in blood pressure, fetal growth restriction, and innate immune activation in normal pregnant rats and in a preclinical rat model of preeclampsia

    Two important clinical features of preeclampsia (PE) are hypertension and fetal growth restriction. The reduced uterine perfusion pressure (RUPP)...

    Mark W. Cunningham Jr, Lorena M. Amaral, ... Babbette LaMarca in Biology of Sex Differences
    Article Open access 06 January 2021
  5. Monoclonal Antibodies in Solid Organ Transplantation

    In an attempt to target solid organ transplant immunosuppression, monoclonal antibodies directed against key steps in specific immunologic pathways...
    Nicole A. Pilch, Holly B. Meadows, Rita R. Alloway in Pharmaceutical Biotechnology
    Chapter 2024
  6. Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience

    Purpose

    This study aimed to investigate the potential impact of tacrolimus (TAC) exposure on clinical outcomes after lung transplantation.

    ...
    Wenwen Du, **aoxing Wang, ... **anbo Zuo in European Journal of Clinical Pharmacology
    Article 16 February 2024
  7. Risk factors of early bacterial infection and analysis of bacterial composition, distribution and drug susceptibility after cadaveric liver transplantation

    Background

    This study provided a theoretical basis for the clinical diagnosis and treatment of bacterial infection after liver transplantation through...

    Min Liu, Cuiying Li, ... Qiquan Wan in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 31 July 2023
  8. Induction Therapy and Therapeutic Antibodies

    Prevention of allograft rejection is one of the crucial goals in solid organ transplantation to ensure durability of the graft and is chiefly...
    Andriana Nikolova, Jignesh K. Patel in Pharmacology of Immunosuppression
    Chapter 2022
  9. A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient

    Background

    Ganciclovir and its prodrug, valganciclovir, are first-line agents for cytomegalovirus infection prophylaxis after lung transplantation....

    Yoshiki Katada, Keisuke Umemura, ... Tomohiro Terada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 07 June 2024
  10. Novel Immunosuppression in Solid Organ Transplantation

    Solid organ transplantation and survival has improved tremendously in the last few decades, much of the success has been attributed to the...
    Prasad Konda, Reshma Golamari, Howard J. Eisen in Pharmacology of Immunosuppression
    Chapter 2022
  11. The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events

    Our study is the first study to investigate the effect of SNPs in CYP3A5 , CYP3A4 , ABCB1 and POR genes on the incidence of tremors, nephrotoxicity,...

    Amani Abderahmene, Yassine khalij, ... Ali Bouslama in The Pharmacogenomics Journal
    Article 22 January 2024
  12. Development and Application of a Physiologically-Based Pharmacokinetic Model to Predict the Pharmacokinetics of Therapeutic Proteins from Full-term Neonates to Adolescents

    Physiologically-based pharmacokinetic (PBPK) modelling provides an integrated framework to predict the disposition of small molecule drugs in...

    **an Pan, Felix Stader, ... Masoud Jamei in The AAPS Journal
    Article 24 May 2020
  13. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

    Background

    Tacrolimus is a key drug in immunosuppressive therapy following lung transplantation. The blood tacrolimus levels are likely to fluctuate...

    Yoshiki Katada, Shunsaku Nakagawa, ... Tomohiro Terada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 October 2022
  14. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients

    CYP3A5 genetic variants are associated with tacrolimus metabolism. Controversy remains on whether CYP3A4 increased [* 1B (rs2740574), * 1 G ...

    Michelle Liu, Savine Hernandez, ... Sara L. Van Driest in The Pharmacogenomics Journal
    Article 15 February 2024
  15. Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody

    Intensive immunosuppression has enabled liver transplantation even in recipients with preformed donor-specific antibodies (DSA), an independent risk...

    Shuhei Egashira, Akatsuki Kubota, ... Tatsushi Toda in Journal of NeuroVirology
    Article Open access 05 September 2023
  16. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients

    Pneumocystis jirovecii  pneumonia (PJP) is difficult to be diagnosed, so this study explored if PJP could be diagnosed by metagenomic next-generation...

    Feng Zhang, Jia Chen, ... Qiquan Wan in European Journal of Clinical Microbiology & Infectious Diseases
    Article 21 April 2021
  17. Adverse Effects of Immunosuppression: Infections

    Immunosuppressive therapies are currently indicated for a wide range of diseases. As new agents emerge and indications evolve the landscape grows...
    Guy Handley, Jonathan Hand in Pharmacology of Immunosuppression
    Chapter 2021
  18. Decreased frequency of Th22 cells and IL-22 cytokine in kidney transplant patients with active cytomegalovirus infection

    Background

    The immunity of CD4 + T cell subsets against human cytomegalovirus (HCMV) is considerable due to their essential role in controlling the...

    Yashgin Hassanzadeh, Ramin Yaghobi, ... Bita Geramizadeh in BMC Immunology
    Article Open access 04 July 2023
  19. Monoclonal Antibodies: From Structure to Therapeutic Application

    The exciting field of therapeutic monoclonal antibodies (mAbs) had its origins when Köhler and Milstein presented their murine hybridoma technology...
    Rong Deng, Junyi Li, ... Chunze Li in Pharmaceutical Biotechnology
    Chapter 2024
Did you find what you were looking for? Share feedback.